Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
Tuesday, April 30th 2024, 3:07:16 pm
article
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit
Breaking
Gov. Kathy Hochul faces blowback from NY Dems who say she stripped key guardrails from a state AI safety bill under pressure from major industry players....
Legal group says judge censored accurate information about DNA testing in E. Jean Carroll case...
